The first report of rhinosinusitis by Rhizopus delemar in a patient with severe COVID-19 in Iran: a case report
In this report, we present the first documented case of human infection with R. delemar in a patient with coronavirus disease 2019 infection, who also exhibited rhinosinusitis mucormycosis. R. delemar appears to be an emerging agent of rhinosinusitis mucormycosis in this region. Furthermore, prompt diagnosis and the exploration of alternative antifungal treatments, beyond amphotericin B, may be crucial for effectively managing patients with R. delemar infections.
Authors
- Jos Houbraken (ORCID: https://orcid.org/0000-0003-4893-4438)
- Hossein Zarrinfar (ORCID: https://orcid.org/0000-0002-1449-4668)
- Ya Bin Zhou (ORCID: https://orcid.org/0000-0001-5775-3861)
- Mehdi Bakhshaee (ORCID: https://orcid.org/0000-0001-9590-4798)
- Mohammad Javad Najafzadeh (ORCID: https://orcid.org/0000-0001-8974-2358)
- Seyedeh Sabereh Mojtahedi
- Neginsadat Hosseinikargar
Institutions
- Mashhad University of Medical Sciences (IR)
- Capital Medical University (CN)
- Westerdijk Fungal Biodiversity Institute (NL)
- Beijing Children’s Hospital (CN)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2024-11-05
- DOI
- https://doi.org/10.1186/s13256-024-04873-w
- Citations
- 3
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Mashhad University of Medical Sciences